Photodynamic therapy of actinic keratosis at varying fluence rates: Assessment of photobleaching, pain and primary clinical outcome

British Journal of Dermatology

Volumn 151, Issue 6, 2004, Pages 1204-1212

  Ericson, M B ^a   Sandberg, C ^b   Stenquist, B ^b   Gudmundson, F ^a   Karlsson, M ^c   Ros, A M ^c   Rosen A ^a   Larko O ^b   Wennberg, A M ^b   Rosdahl, I ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Actinic keratosis; Fluence rate; Fluorescence imaging; Pain; Photobleaching; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; OXYGEN; PORPHIN;

ACTINIC KERATOSIS; AGED; ARTICLE; BLEACHING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FILTER; FLUENCE RATE; FLUORESCENCE; FLUORESCENCE IMAGING; FOLLOW UP; HUMAN; IMAGING; LIGHT; LIGHT DOSE; MALE; MULTICENTER STUDY; OPEN STUDY; PAIN; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; SPECTRUM; TISSUE OXYGENATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGED; AMINOLEVULINIC ACID; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 19944404737     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06211.x     Document Type: Article

References (41)

1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143-8.
2. Wennberg AM, Lindholm LE, Alpsten M, Larkö O. Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevutinic acid and a filtered xenon lamp. Arch Dermatol Res 1996; 288: 561-4.
3. Jeffes EW, McCullough JL, Weinstein GD et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol 1997; 133: 727-32.
4. Peng Q, Warloe T, Berg K et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79: 2282-308.
5. Fink-Puches R, Hofer A, Smolle J et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B 1997; 41: 145-51.
6. Karrer S, Baumler W, Abels C et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999; 25: 51-9.
7. Stefanidou M, Tosca A, Themelis G et al. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. Eur J Dermatol 2000; 10: 351-6.
8. Szeimies RM, Karrer S, Radakovic-Fijan S et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62.
9. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-67.
10. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413; quiz 4-6.
11. Grapengiesser S, Ericson M, Gudmundsson F et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-7.
12. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-92.
13. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976; 36: 2326-9.
14. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985; 45: 1608-10.
15. Foote CS. Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems. Science 1968; 162: 963-70.
16. Iinuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer 1994; 70: 21-8.
17. Malik Z, Dishi M, Garini Y. Fourier transform multipixel spectroscopy and spectral imaging of protoporphyrin in single melanoma cells. Photochem Photobiol 1996; 63: 608-14.
18. Peng Q, Moan J, Warloe T et al. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 1992; 52: 433-43.
19. Inhoffen HH, Brockmann H Jr, Bliesener KM. Chlorophyll and hemin. Photoprotoporphyrins and their transformation into spirographis- and isospirographis-porphyrin. Justus Liebigs Ann Chem 1969; 730: 173-85.
20. Cox GS, Whitten DG. Mechanisms for the photooxidation of protoporphyrin IX in solution. J Am Chem Soc 1982; 104: 516-21.
21. Krieg M, Whitten DG. Self-sensitized photooxidation of protoporphyrin IX and related free-base porphyrins in natural and model membrane systems. Evidence for novel photooxidation pathways involving amino acids. J Am Chem Soc 1984; 106: 2477-9.
22. Mang TS, Dougherty TJ, Potter WR et al. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol 1987; 45: 501-6.
23. Robinson DJ, de Bruijn HS, van der Veen N et al. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 1998; 67: 140-9.
24. Robinson DJ, de Bruijn HS, van der Veen N et al. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem Photobiol 1999; 69: 61-70.
25. Bagdonas S, Ma LW, Iani V et al. Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study. Photochem Photobiol 2000; 72: 186-92.
26. Juzenas P, Iani V, Bagdonas S et al. Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light. J Photochem Photobiol B 2001; 61: 78-86.
27. Finlay JC, Conover DL, Hull EL, Foster TH. Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo. Photochem Photobiol 2001; 73: 54-63.
28. König K, Schneckenburger H, Ruck A, Steiner R. In vivo photo-product formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol B 1993; 18: 287-90.
29. Georgakoudi I, Foster TH. Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry. Photochem Photobiol 1998; 67: 612-25.
30. Ericson MB, Grapengiesser S, Gudmundson F et al. A spectroscopic study of the photobleaching of protoporphyrin IX in solution. Lasers Med Sci 2003; 18: 56-62.
31. Tromberg BJ, Orenstein A, Kimel S et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol 1990; 52: 375-85.
32. Foster TH, Murant RS, Bryant RG et al. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 1991; 126: 296-303.
33. Foster TH, Hartley DF, Nichols MG, Hilf R. Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res 1993; 53: 1249-54.
34. Sitnik TM, Hampton JA, Henderson BW. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer 1998; 77: 1386-94.
35. Sitnik TM, Henderson BW. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem Photobiol 1998; 67: 462-6.
36. Iinuma S, Schomacker KT, Wagnieres G et al. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res 1999; 59: 6164-70.
37. Glasbey CA. A review of image warping methods. J Appl Stat 1998; 25: 155-71.
38. Maxwell AE. Analysing Qualitative Data. London: Methuen 1961.
39. Miller JC, Miller JN. Statistics for Analytical Chemistry. 3rd edn. Bodmin: Ellis Horwood and Prentice Hall, 1993.
40. Hewett J, Nadeau V, Ferguson J et al. The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers. Photochem Photobiol 2001; 73: 278-82.
41. van den Akker JT, de Bruijn HS, van Beijersbergen Henegouwen GM et al. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer. Photochem Photobiol 2000; 72: 399-406.